{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:33:29Z","timestamp":1790062409851,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,18]],"date-time":"2011-03-18T00:00:00Z","timestamp":1300406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1745-6215-12-81","type":"journal-article","created":{"date-parts":[[2011,3,18]],"date-time":"2011-03-18T15:14:19Z","timestamp":1300461259000},"source":"Crossref","is-referenced-by-count":52,"title":["Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit"],"prefix":"10.1186","volume":"12","author":[{"given":"Patrick","family":"Royston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike M-S","family":"Barthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh KB","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Choodari-Oskooei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Isham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,18]]},"reference":[{"key":"622_CR1","volume-title":"US Dept of Health and Human Services","author":"US Food and Drug Administration","year":"2004","unstructured":"US Food and Drug Administration: Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products. US Dept of Health and Human Services. 2004"},{"key":"622_CR2","volume-title":"Statistical Monitoring of Clinical Trials - A Unified Approach","author":"MA Proschan","year":"2006","unstructured":"Proschan MA, Lan KKG, Wittes J: Statistical Monitoring of Clinical Trials - A Unified Approach. 2006, New York: Springer"},{"key":"622_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2307\/2343787","volume":"132","author":"P Armitage","year":"1969","unstructured":"Armitage P, McPherson CK, Rowe BC: Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A. 1969, 132: 235-244. 10.2307\/2343787.","journal-title":"Journal of the Royal Statistical Society, Series A"},{"key":"622_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2307\/2336502","volume":"70","author":"K Lan","year":"1983","unstructured":"Lan K, DeMets D: Discrete sequential boundaries for clinical trials. Biometrika. 1983, 70: 659-663. 10.2307\/2336502.","journal-title":"Biometrika"},{"key":"622_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2307\/2530245","volume":"35","author":"PC O'Brien","year":"1979","unstructured":"O'Brien PC, Fleming TR: A multiple testing procedure for clinical trials. Biometrics. 1979, 35: 549-556.","journal-title":"Biometrics"},{"key":"622_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1177\/009286150103500408","volume":"35","author":"S Pampallona","year":"2001","unstructured":"Pampallona S, Tsiatis A, Kim KM: Interim monitoring of group sequential trials using spending functions for the type I and II error probabilities. Drug Information Journal. 2001, 35: 1113-1121.","journal-title":"Drug Information Journal"},{"key":"622_CR7","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/sim.1430","volume":"22","author":"P Royston","year":"2003","unstructured":"Royston P, Parmar MKB, Qian W: Novel designs for multi-arm clinical trials with survival outcomes, with an application in ovarian cancer. Statistics in Medicine. 2003, 22: 2239-2256. 10.1002\/sim.1430.","journal-title":"Statistics in Medicine"},{"key":"622_CR8","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/JCO.2008.19.1684","volume":"27","author":"MA Bookman","year":"2009","unstructured":"Bookman MA, Brady MF, McGuire WP, Harper PG, Alberts DS, Friedlander M, Colombo N, Fowler JM, Argenta PA, Geest KD, Mutch DG, Burger RA, Swart AM, Trimble EL, Accario-Winslow C, Roth LM: Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup. Journal of Clinical Oncology. 2009, 27: 1419-1425. 10.1200\/JCO.2008.19.1684.","journal-title":"Journal of Clinical Oncology"},{"key":"622_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.clon.2008.07.002","volume":"20","author":"ND James","year":"2008","unstructured":"James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Anderson J, Popert RJ, Sanders K, Morgan RC, Stansfeld J, Dwyer J, Masters J, Parmar MKB: STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer - A Multi-Arm Multi-Stage Randomised Controlled Trial. Clinical Oncology. 2008, 20: 577-581. 10.1016\/j.clon.2008.07.002.","journal-title":"Clinical Oncology"},{"key":"622_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/biomet\/68.1.311","volume":"68","author":"AA Tsiatis","year":"1981","unstructured":"Tsiatis AA: The asymptotic joint distribution of the efficient scores test for the propor- tional hazards model calculated over time. Biometrika. 1981, 68: 311-315. 10.1093\/biomet\/68.1.311.","journal-title":"Biometrika"},{"key":"622_CR11","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2307\/2533857","volume":"54","author":"R Betensky","year":"1998","unstructured":"Betensky R: Construction of a continuous stopping boundary from an alpha spending function. Biometrics. 1998, 54: 1061-1071. 10.2307\/2533857.","journal-title":"Biometrics"},{"key":"622_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/1740774510369019","volume":"7","author":"B Freidlin","year":"2010","unstructured":"Freidlin B, Korn EL, Gray R: A general inefficacy interim monitoring rule for randomized clinical trials. Clinical Trials. 2010, 7: 197-208. 10.1177\/1740774510369019.","journal-title":"Clinical Trials"},{"key":"622_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/1467-985X.00091","volume":"161","author":"P Royston","year":"1998","unstructured":"Royston P, Wright EM: A method for estimating age-specific reference intervals (\"normal ranges\") based on fractional polynomials and exponential transformation. Journal of the Royal Statistical Society, Series A. 1998, 161: 79-101.","journal-title":"Journal of the Royal Statistical Society, Series A"},{"key":"622_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/sim.4780080407","volume":"8","author":"RL Prentice","year":"1989","unstructured":"Prentice RL: Surrogate endpoints in clinical trials: definition and operational criteria. Statistics in Medicine. 1989, 8: 431-440. 10.1002\/sim.4780080407.","journal-title":"Statistics in Medicine"},{"key":"622_CR15","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1002\/sim.2517","volume":"25","author":"FMS Barthel","year":"2006","unstructured":"Barthel FMS, Babiker A, Royston P, Parmar MKB: Evaluation of sample size and power for multi-arm survival trials allowing for non-uniform accrual, non-proportional hazards, loss to follow-up and cross-over. Statistics in Medicine. 2006, 25: 2521-2542. 10.1002\/sim.2517.","journal-title":"Statistics in Medicine"},{"key":"622_CR16","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/sim.1203","volume":"21","author":"P Royston","year":"2002","unstructured":"Royston P, Parmar MKB: Flexible Parametric Proportional-Hazards and Proportional-Odds Models for Censored Survival Data, with Application to Prognostic Modelling and Estimation of Treatment Effects. Statistics in Medicine. 2002, 21: 2175-2197. 10.1002\/sim.1203.","journal-title":"Statistics in Medicine"},{"key":"622_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536867X0100100101","volume":"1","author":"P Royston","year":"2001","unstructured":"Royston P: Flexible parametric alternatives to the Cox model, and more. Stata Journal. 2001, 1: 1-28.","journal-title":"Stata Journal"},{"key":"622_CR18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1536867X0900900206","volume":"9","author":"PC Lambert","year":"2009","unstructured":"Lambert PC, Royston P: Further development of flexible parametric models for survival analysis. Stata Journal. 2009, 9: 265-290.","journal-title":"Stata Journal"},{"key":"622_CR19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/sim.1455","volume":"22","author":"M Posch","year":"2003","unstructured":"Posch M, Bauer P, Brannath W: Issues in Designing Flexible Trials. Statistics in Medicine. 2003, 22: 953-969. 10.1002\/sim.1455.","journal-title":"Statistics in Medicine"},{"key":"622_CR20","volume-title":"Point Processes","author":"DR Cox","year":"1980","unstructured":"Cox DR, Isham V: Point Processes. 1980, London: Chapman and Hall"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-12-81\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-81.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-81","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-81.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T15:01:38Z","timestamp":1548169298000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-12-81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,18]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-12-81","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,18]]},"article-number":"81"}}